Joelle Hallak - Associate Director, HEOR Real World Evidence (RWE) Analytics - AbbVie | LinkedIn
Posttraumatic Growth in Breast Cancer Survivors: Constructive and Illusory Aspects - Pat‐Horenczyk - 2015 - Journal of Traumatic Stress - Wiley Online Library
Findings from Can-Fite's Phase II Liver Cancer Study were Presented at ASCO Annual Meeting Late-Breaking Session | Business Wire
Pharmaceuticals | Free Full-Text | Tumor-Targeted Fluorescent Proteinoid Nanocapsules Encapsulating Synergistic Drugs for Personalized Cancer Therapy
Prof. Naphtali Savion | Sackler Faculty of Medicine
References in Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial - The Lancet
MD Anderson study finds ribociclib improves survival for women with metastatic breast cancer | MD Anderson Cancer Center
Matthew L. Meyerson, MD, PhD - DF/HCC
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib - Annals of Oncology
Transnational cancer research lab | Felsenstein Medical Research Center
Exclusive program launched for medical industry leaders - Globes
Joelle Hallak - Associate Director, HEOR Real World Evidence (RWE) Analytics - AbbVie | LinkedIn
COVID-fighting antibodies last 4+ months in 87% of cancer patients: Israeli MDs | The Times of Israel
Pharmaceuticals | Free Full-Text | Tumor-Targeted Fluorescent Proteinoid Nanocapsules Encapsulating Synergistic Drugs for Personalized Cancer Therapy
References in First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised ...
Joelle Hallak - Associate Director, HEOR Real World Evidence (RWE) Analytics - AbbVie | LinkedIn
Leadership – CTG-Pharma
EX-99.1 2 f6k060319ex99-1_canfitebio.htm PRESS RELEASE DATED JUNE 3, 2019 Exhibit
Cancers | Special Issue : Hepatobiliary Cancers
Posttraumatic Growth in Breast Cancer Survivors: Constructive and Illusory Aspects - Pat‐Horenczyk - 2015 - Journal of Traumatic Stress - Wiley Online Library
Study: COVID-19 shots shown effective in cancer patients up to 4 months later - UPI.com
COVID Booster May Benefit Active-Treatment Cancer Patients
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib - Annals of Oncology
Prof. Ruth Shalgi-Harsina | Sackler Faculty of Medicine
UT Southwestern Radiation Oncology - Congratulations to Dr. Prasanna Alluri, Assistant Professor of Radiation Oncology at UT Southwestern, and Dr. Salomon Stemmer, Professor in Oncology at Rabin Medical Center, for being awarded
Past Seminars - Health Care Management
Study: COVID-19 shots shown effective in cancer patients up to 4 months later - UPI.com
